Novo Nordisk A/S (NONOF)
OTCMKTS
· Delayed Price · Currency is USD
112.70
+0.70 (0.63%)
Oct 30, 2024, 11:08 AM EDT
Novo Nordisk Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 258,003 | 232,261 | 176,954 | 140,800 | 126,946 | 122,021 | Upgrade
|
Revenue Growth (YoY) | 28.15% | 31.26% | 25.68% | 10.91% | 4.04% | 9.11% | Upgrade
|
Cost of Revenue | 39,917 | 35,765 | 28,448 | 23,658 | 20,932 | 20,088 | Upgrade
|
Gross Profit | 218,086 | 196,496 | 148,506 | 117,142 | 106,014 | 101,933 | Upgrade
|
Selling, General & Admin | 63,205 | 61,598 | 50,684 | 41,058 | 36,886 | 35,830 | Upgrade
|
Research & Development | 36,246 | 31,029 | 23,287 | 17,199 | 15,462 | 14,220 | Upgrade
|
Other Operating Expenses | 62 | -119 | -1,034 | -332 | -460 | -600 | Upgrade
|
Operating Expenses | 99,513 | 92,508 | 72,937 | 57,925 | 51,888 | 49,450 | Upgrade
|
Operating Income | 118,573 | 103,988 | 75,569 | 59,217 | 54,126 | 52,483 | Upgrade
|
Interest Expense | -542 | -542 | -378 | -289 | -390 | -220 | Upgrade
|
Interest & Investment Income | 1,069 | 1,069 | 239 | 231 | 337 | 65 | Upgrade
|
Earnings From Equity Investments | 81 | 81 | -189 | -24 | 149 | -137 | Upgrade
|
Currency Exchange Gain (Loss) | 1,058 | 1,652 | -4,651 | 344 | -747 | -3,212 | Upgrade
|
Other Non Operating Income (Expenses) | -229 | -197 | -181 | -122 | -150 | -281 | Upgrade
|
EBT Excluding Unusual Items | 120,010 | 106,051 | 70,409 | 59,357 | 53,325 | 48,698 | Upgrade
|
Gain (Loss) on Sale of Investments | 37 | 37 | -587 | 296 | -195 | -145 | Upgrade
|
Asset Writedown | -7,114 | -1,414 | -760 | -573 | - | - | Upgrade
|
Pretax Income | 112,933 | 104,674 | 69,062 | 59,080 | 53,130 | 48,553 | Upgrade
|
Income Tax Expense | 23,035 | 20,991 | 13,537 | 11,323 | 10,992 | 9,602 | Upgrade
|
Net Income | 89,898 | 83,683 | 55,525 | 47,757 | 42,138 | 38,951 | Upgrade
|
Net Income to Common | 89,898 | 83,683 | 55,525 | 47,757 | 42,138 | 38,951 | Upgrade
|
Net Income Growth | 33.70% | 50.71% | 16.27% | 13.33% | 8.18% | 0.84% | Upgrade
|
Shares Outstanding (Basic) | 4,464 | 4,483 | 4,531 | 4,593 | 4,668 | 4,749 | Upgrade
|
Shares Outstanding (Diluted) | 4,477 | 4,495 | 4,545 | 4,606 | 4,680 | 4,757 | Upgrade
|
Shares Change (YoY) | -0.90% | -1.10% | -1.34% | -1.58% | -1.63% | -1.89% | Upgrade
|
EPS (Basic) | 20.14 | 18.67 | 12.26 | 10.40 | 9.03 | 8.20 | Upgrade
|
EPS (Diluted) | 20.08 | 18.62 | 12.22 | 10.37 | 9.01 | 8.19 | Upgrade
|
EPS Growth | 34.93% | 52.37% | 17.84% | 15.16% | 9.95% | 2.82% | Upgrade
|
Free Cash Flow | 81,155 | 83,102 | 66,741 | 48,665 | 46,126 | 37,850 | Upgrade
|
Free Cash Flow Per Share | 18.13 | 18.49 | 14.69 | 10.57 | 9.86 | 7.96 | Upgrade
|
Dividend Per Share | 9.900 | 9.400 | 6.200 | 5.200 | 4.550 | 4.175 | Upgrade
|
Dividend Growth | 39.93% | 51.61% | 19.23% | 14.29% | 8.98% | 2.45% | Upgrade
|
Gross Margin | 84.53% | 84.60% | 83.92% | 83.20% | 83.51% | 83.54% | Upgrade
|
Operating Margin | 45.96% | 44.77% | 42.71% | 42.06% | 42.64% | 43.01% | Upgrade
|
Profit Margin | 34.84% | 36.03% | 31.38% | 33.92% | 33.19% | 31.92% | Upgrade
|
Free Cash Flow Margin | 31.46% | 35.78% | 37.72% | 34.56% | 36.34% | 31.02% | Upgrade
|
EBITDA | 126,561 | 109,813 | 80,875 | 63,770 | 58,565 | 56,310 | Upgrade
|
EBITDA Margin | 49.05% | 47.28% | 45.70% | 45.29% | 46.13% | 46.15% | Upgrade
|
D&A For EBITDA | 7,988 | 5,825 | 5,306 | 4,553 | 4,439 | 3,827 | Upgrade
|
EBIT | 118,573 | 103,988 | 75,569 | 59,217 | 54,126 | 52,483 | Upgrade
|
EBIT Margin | 45.96% | 44.77% | 42.71% | 42.06% | 42.64% | 43.01% | Upgrade
|
Effective Tax Rate | 20.40% | 20.05% | 19.60% | 19.17% | 20.69% | 19.78% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.